Compugen Ltd. (Nasdaq: CGEN) (TASE: CGEN) a clinical-stage cancer immunotherapy company and a pioneer in computational target discovery, today announced results generated in a joint research ...
Gene structure information identified by combining Compugen's AI/ML predictive computational discovery platform, Unigentm with Ultima's UG 100tm sequencing platform to better understand tumor biology ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback